Showing results (351-360 of 391) with videos related to

Sort By:
Pageof 40
Annales De Pathologie|July 2, 2019
[GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting]Aurélie Maran-Gonzalez, Camille Franchet, Raphaëlle Duprez-Paumier, et al.
ESMO Open|April 12, 2018
Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut CurieClémence Basse, Claire Morel, Marie Alt, et al.
Nature Communications|January 11, 2022
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-toleranceGabriel Therizols, Zeina Bash-Imam, Baptiste Panthu, et al.
Translational Oncology|September 13, 2019
Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute ParisLaurence Slembrouck, Lauren Darrigues, Cecile Laurent, et al.
BMC Cancer|July 24, 2013
SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesJocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, et al.
Cell|March 24, 2022
Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancerRodrigo Nalio Ramos, Yoann Missolo-Koussou, Yohan Gerber-Ferder, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 3, 2022
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancerMaxim De Schepper, Anne Vincent-Salomon, Matthias Christgen, et al.
Annales De Pathologie|August 16, 2021
[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France]Camille Franchet, Lounes Djerroudi, Aurélie Maran-Gonzalez, et al.
Annales De Pathologie|December 3, 2014
[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]Frédérique Penault-Llorca, Anne Vincent-Salomon, Gaëtan MacGrogan, et al.
The Journal of Pathology|February 25, 2012
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancersRachael Natrajan, Alan Mackay, Maryou B Lambros, et al.
Pageof 40